"Get to Know MCS” is an internal podcast hosted by Curt Hanson, M.D., featuring the people and teams who expand Mayo Clinic knowledge to meet the needs of patients served through Mayo Collaborative Services.

In this episode, Dr. Hanson interviews Dennis Mc Neil, senior director of international sales for MCL. They discuss Dennis' background and highlights from his long career with Mayo Clinic, what people might be surprised to learn about international business affairs, and the impact that MCL has on communities around the world.

Get To Know MCS: Dennis Mc Neil

Blood Donor Center - iHeartRadio Interview

We recently sat down with Jane Hermansen, Network and Outreach Development Manager at Mayo Clinic Medical Laboratories in Rochester, Minnesota, to discuss Clinical Laboratory Management Association's (CLMA) upcoming KnowledgeLab 2017, held March 26-29 in Nashville, TN.

KnowledgeLab 2017 Preview with Jane Hermansen

Audio Insights with Dr. Morice: USCAP Award Winners

Chat with the Chair: Leadership Vol. 1

Dietrich Matern, M.D., Ph.D., Chair of the Division of Laboratory Genetics and a Consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discuss the RUSP and its importance in newborn screening.

What is the RUSP?

Dietrich Matern, M.D., Ph.D., Chair of the Division of Laboratory Genetics and a Consultant in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses the clinical action enabled by newborn screening.

Clinical Action Enabled by Newborn Screening

Learn how Mayo Clinic researchers discovered a new bacterial species that causes Lyme disease in people.

"Naming a Bacterial Species," by Bobbi Pritt, M.D.

Nicole Hoppman, Ph.D. discusses clinical application of Cell-Free DNA Prenatal Screen. This test detects common chromosome abnormalities without the risk of pregnancy loss associated with invasive prenatal procedures. Chromosomal aneuploidy is the leading known genetic cause of miscarriage and congenital birth defects, including Down syndrome, trisomy 13, and trisomy 18.

This fetal DNA screening test is not diagnostic. Abnormal results should be confirmed with invasive prenatal diagnostic testing (such as chorionic villi sampling or amniocentesis). Genetic consultation is recommended.

NIPS Clinical Application

On Tuesday, we had a quick conversation with Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D. We discussed their presentations and sessions.

AACC 2017: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

Sue Cloutier, Operations Manager, and Julie Bicknese, Supervisor, at Mayo Clinic, talk about their upcoming breakout session on leveraging customer service at Leveraging the Laboratory 2017 in Philadelphia, Pennsylvania.

Leveraging the Laboratory: Sue Cloutier & Julie Bicknese

James Stubbs, M.D., provides an overview of the upcoming TransFuse Conference in San Antonio, Texas.

TransFuse Conference Overview with James Stubbs, M.D.

Nicole Kang, one of the speakers for the 2018 Phlebotomy Conference, provides a snapshot of what her breakout session geared towards phlebotomy managers and supervisors will entail.

Audio Insights: Phlebotomy 2018 Breakout Session Snapshot with Nicole Kang

Christopher Klein, a Neurologist at Mayo Clinic, provides an overview of  neuromuscular testing through Mayo Medical Laboratories. He discusses which types of patients should be tested, the benefits of our approach, how this approach improves upon previous methods, and the role that functional assays play in diagnosis.

Neuromuscular Overview

A. Sebastian Lopez Chiriboga, M.D. discusses his presentation during the Neuromyelitis Optica Spectrum Disorder and other Autoimmune Disorders session during AAN 2018.

Platform Presentation: Persistence of MOG-IgG Seropositivity Predicts Relapse After ADEM at #AANAM

Shirley Roque is an Outreach Program Coordinator for Mayo Medical Laboratories and is on the planning committee for the Leveraging the Laboratory Conference that is taking place on September 18-19, 2018 in Rochester, Minnesota.

Audio Insights: Leveraging the Laboratory Conference Overview with Shirley Roque

Linnea Baudhuin, Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic, provides an overview of the new familial hereditary hemorrhagic telangiectasia gene panel available through Mayo Medical Laboratories. She discusses which types of patients should be tested, how this approach improves upon previous methods, and what clinical action can be taken from the results of this test.

Testing Overview

William Morice, II, M.D., Ph.D., sat down with Marie Brown to recap her time spent at Mayo Clinic and wish her well in her retirement.

Chat with the Chair: Marie Brown

Mayo Medical Laboratories President William Morice, M.D., Ph.D., sits down with the new Medical Director of Mayo Medical Laboratories, Mohamed Salama, M.D. The two discuss his role and career history.

Chat with the Chair: Mohamed Salama, M.D.

What Clinical Action Is Enabled by the Results of this Testing?

What Clinical Action is Enabled by the Results of this Testing

How Does this Testing Improve Upon Previous Testing Approaches?

When Should I Order this Testing?

Placenta Pathology Services

Urologic Pathology Services

Mayo Clinic Laboratories is a global reference laboratory operating within Mayo Clinic's Department of Laboratory Medicine and Pathology.

Mayo Clinic Laboratories

Popular tracks